drugset / Trial / NCT00853450
Bleeding Time Study With AZD6482, Clopidogrel and ASA
RandomizedCrossoverOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the effect of AZD6482 and clopidogrel on bleeding time when taken together with low-dose ASA.
Timeline
- Start
- 2009-02
- Primary completion
- —
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD6482 | Small molecule | — | Intravenous |
| Comparator | Clopidogrel | Small molecule | 75 mg | Oral |
| Background | ASA | Unknown | 75 mg | Oral |
Indications
No indication recorded.